KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.86 $42.36 Thursday, 25th Apr 2024 CLDX stock ended at $36.26. This is 2.05% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.61% from a day low at $35.86 to a day high of $37.16.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Nov 30, 2023 $29.87 $30.25 $29.34 $30.21 769 271
Nov 29, 2023 $28.43 $29.62 $28.07 $29.31 853 921
Nov 28, 2023 $29.08 $29.30 $28.15 $28.21 571 057
Nov 27, 2023 $28.49 $29.28 $28.16 $29.19 642 481
Nov 24, 2023 $27.62 $29.00 $27.62 $28.67 262 654
Nov 22, 2023 $28.30 $28.45 $27.60 $27.75 385 003
Nov 21, 2023 $27.31 $29.07 $27.13 $28.01 850 735
Nov 20, 2023 $29.06 $29.34 $26.92 $27.23 1 532 762
Nov 17, 2023 $28.11 $29.15 $27.90 $29.09 451 275
Nov 16, 2023 $28.39 $28.39 $27.09 $27.79 761 455
Nov 15, 2023 $27.69 $30.01 $27.69 $28.53 841 332
Nov 14, 2023 $27.77 $28.50 $27.51 $27.90 1 353 978
Nov 13, 2023 $26.95 $27.05 $26.19 $26.97 1 189 171
Nov 10, 2023 $26.91 $27.29 $26.21 $26.94 1 933 369
Nov 09, 2023 $26.66 $27.01 $25.08 $25.78 1 822 018
Nov 08, 2023 $27.35 $28.49 $26.17 $26.50 2 826 858
Nov 07, 2023 $29.89 $31.22 $28.91 $29.02 1 240 010
Nov 06, 2023 $32.98 $33.55 $28.80 $29.35 4 007 192
Nov 03, 2023 $25.40 $26.92 $24.72 $25.98 1 173 745
Nov 02, 2023 $24.01 $24.82 $23.72 $24.01 602 165
Nov 01, 2023 $23.44 $24.01 $23.12 $23.57 422 561
Oct 31, 2023 $22.63 $23.59 $22.27 $23.52 407 855
Oct 30, 2023 $22.72 $23.30 $22.11 $22.70 362 400
Oct 27, 2023 $23.43 $26.20 $22.48 $22.61 334 740
Oct 26, 2023 $23.72 $24.06 $23.16 $23.30 401 483
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT